Physician profile
Divya Kaila
NPI 1245425370
$4,106.87
in general payments reported to CMS, 2019-2025
9 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $3,501 · 2024: $477 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $643 · Travel and Lodging: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $642.96 |
| Travel and Lodging | $463.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,480.70 | 2023 | Ion, Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $176.46 | 2024 | Breztri, Airsupra |
| Inspire Medical Systems, INC. | $113.16 | 2025 | Inspire |
| Glaxosmithkline, LLC. | $110.35 | 2023-2025 | Nucala, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.25 | 2024 | Ofev |
| Genzyme Corporation | $64.22 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $33.73 | 2024 | Dupixent |
| Axsome Therapeutics, INC. | $20.64 | 2024 | Sunosi |
| Bayer Healthcare Pharmaceuticals INC. | $16.36 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Divya Kaila listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.